The Quest Diagnostics Diabetes, Newly Diagnosed and Monitoring Panel offers you a simple way to follow American Diabetes Association (ADA) recommendations for diabetes lab testing in patients with type 2 diabetes.1 Using this single panel that adheres to testing guidelines, you’ll be able to detect the onset of complications as early as possible and make informed decisions about how to proceed with treatment.
The Diabetes, Newly Diagnosed and Monitoring Panel assesses:
- Fasting lipid levels
- Fasting glucose
- Liver function tests (albumin, total and direct bilirubin, alkaline phosphatase, total protein, ALT, AST)
- Urinary albumin excretion (UAE)
- Spot urine albumin-to-creatinine ratio
- Serum creatinine/eGFR
Use the Diabetes, Newly Diagnosed and Monitoring Panel as part of your routine annual visit to get a baseline snapshot of key parameters in newly diagnosed patients.